Valeo Pharma Inc (OTCPK:VPHIF)
$ 0.0469 0 (0%) Market Cap: 526,000.00 Enterprise Value: 48.46 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Valeo Pharma Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript

May 03, 2022 / 03:00PM GMT
Release Date Price: $0.41
Steve Saviuk
Valeo Pharma Inc. - CEO

It's great to be back live in front of everyone being able to talk about and inform you about Valeo Pharma. I'd like to thank Jolyon, Bryan, and the whole Bloom Burton team and -- for putting this event on. It's a great event and shining a light on the Canadian healthcare sector, which they do in a tireless fashion. We -- all the presenters, I'm sure, really appreciate that.

Valeo Pharma, we stand for innovation and innovation spark's life. I'll start -- just talking a little bit about Valeo now and you'll see the forward-looking statements and then we'll get into -- we think we have a very exciting company. We're looking at a high growth opportunity, high-revenue growth opportunities, certainly over the next five years.

We have some world-class innovative products we're launching in Canada. We're a Canadian pharma company, so we were created -- founded in 2003. We focus on innovative products, the in-licensing and acquisition of those products for the Canadian market. We're looking at commercial-stage products. So typically, post-Phase III launched

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot